brusatol has been researched along with Bile Duct Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, W; Chen, G; Chen, Z; He, B; Li, J; Li, L; Yu, H; Zhao, J; Zheng, J; Zhu, Y | 1 |
1 other study(ies) available for brusatol and Bile Duct Cancer
| Article | Year |
|---|---|
Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Epithelial-Mesenchymal Transition; Humans; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quassins | 2022 |